Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex

Journal of Medicinal Chemistry

Volumn 55, Issue 24, 2012, Pages 11013-11021

  Yamamoto, Natsuho ^a   Renfrew, Anna K ^a   Kim, Byung J ^a   Bryce, Nicole S ^a   Hambley, Trevor W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT COMPLEX; COUMARIN;

ACIDITY; ARTICLE; CANCER CELL; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TARGETING; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY; PROTON TRANSPORT; TUMOR MICROENVIRONMENT;

ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL LINE, TUMOR; COBALT; COORDINATION COMPLEXES; COUMARINS; DRUG SCREENING ASSAYS, ANTITUMOR; FLUORESCENT DYES; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROXAMIC ACIDS; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR MICROENVIRONMENT;

EID: 84871656124     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm3014713     Document Type: Article

References (46)

1. Zeman, E. M.; Brown, J. M.; Lemmon, M. J.; Hirst, V. K.; Lee, W. W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells Int. J. Radiat. Oncol. 1986, 12, 1239-1242 (Pubitemid 16055893)
2. Raghunand, N.; He, X.; van Sluis, R.; Mahoney, B.; Baggett, B.; Taylor, C. W.; Paine-Murrieta, G.; Roe, D.; Bhujwalla, Z. M.; Gillies, R. J. Enhancement of chemotherapy by manipulation of tumour pH Br. J. Cancer 1999, 80, 1005-1011 (Pubitemid 29233921)
3. Wilson, W. R.; Hay, M. P. Targeting hypoxia in cancer therapy Nature Rev. Cancer 2011, 11, 393-410
4. Denny, W. A. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic Future Oncol. 2010, 6, 419-428
5. DeClerck, K.; Elble, R. C. The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy Front. Biosci. 2010, 15, 213-225
6. Gort, E. H.; Groot, A. J.; van der Wall, E.; van Diest, P. J.; Vooijs, M. A. Hypoxic regulation of metastasis via hypoxia-inducible factors Curr. Mol. Med. 2008, 8, 60-67 (Pubitemid 351516825)
7. Boucher, Y.; Baxter, L. T.; Jain, R. K. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy Cancer Res. 1990, 50, 4478-4484 (Pubitemid 20230379)
8. Chauhan, V. P.; Stylianopoulos, T.; Boucher, Y.; Jain, R. K. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies Annu. Rev. Chem. Biomol. Eng. 2011, 2, 281-298
9. Minchinton, A. I.; Tannock, I. F. Drug penetration in solid tumours Nature Rev. Cancer 2006, 6, 583-592 (Pubitemid 44140857)
10. Milbank, J. B.; Stevenson, R. J.; Ware, D. C.; Chang, J. Y.; Tercel, M.; Ahn, G. O.; Wilson, W. R.; Denny, W. A. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7- trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1 H -pyrrolo[3,2- f ]quinoline (seco -6-azaCBI-TMI) as hypoxia selective cytotoxins J. Med. Chem. 2009, 52, 6822-6834
11. Ware, D. C.; Brothers, P. J.; Clark, G. R.; Denny, W. A.; Palmer, B. D.; Wilson, W. R. Synthesis, structures and hypoxia-selective cytotoxicity of cobalt(III) complexes containing tridentate amine and nitrogen mustard ligands Dalton Trans. 2000, 6, 925-932
12. Teicher, B. A.; Abrams, M. J.; Rosbe, K. W.; Herman, T. S. Cytotoxicity, radiosensitization, antitumor activity, and interaction with hyperthermia of a Co(III) mustard complex Cancer Res. 1990, 50, 6971-6975 (Pubitemid 20361100)
13. 4 Chem. Commun. 1991, 17, 1171-1173
14. Ware, D. C.; Palmer, B. D.; Wilson, W. R.; Denny, W. A. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards J. Med. Chem. 1993, 36, 1839-1846 (Pubitemid 23203741)
15. Failes, T. W.; Hambley, T. W. Models of hypoxia activated prodrugs: Co(III) complexes of hydroxamic acids Dalton Trans. 2006, 6, 1895-1901
16. Kim, B. J.; Hambley, T. W.; Bryce, N. S. Visualising the hypoxia selectivity of cobalt(III) prodrugs Chem. Sci. 2011, 2, 2135-2142
17. Yamamoto, N.; Danos, S.; Bonnitcha, P. D.; Failes, T. W.; New, E. J.; Hambley, T. W. Cellular uptake and distribution of cobalt complexes of fluorescent ligands J. Biol. Inorg. Chem. 2008, 13, 861-871
18. Whittaker, M.; Floyd, C. D.; Brown, P.; Gearing, A. J. H. Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors Chem. Rev. 1999, 99, 2735-2776
19. Failes, T. W.; Cullinane, C.; Diakos, C. I.; Yamamoto, N.; Lyons, G. J.; Hambley, T. W. Studies of a Co(III) complex of the MMP inhibitor marimastat: a potential hypoxia activated prodrug Chem.-Eur. J. 2007, 13, 2974-2982 (Pubitemid 46941871)
20. Gallagher, F. A.; Kettunen, M. I.; Day, S. E.; Hu, D.-E.; Ardenkjaer-Larsen, J. H.; in't Zandt, R.; Jensen, P. R.; Karlsson, M.; Golman, K.; Lerche, M. H.; Brindle, K. M. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate Nature 2008, 453, 940-943 (Pubitemid 351832568)
21. Gerweck, L. E.; Vijayappa, S.; Kozin, S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics Mol. Cancer Ther. 2006, 5, 1275-1279 (Pubitemid 43881320)
22. Gillies, R. J.; Raghunand, N.; Garcia-Martin, M. L.; Gatenby, R. A. pH imaging. A review of pH measurement methods and applications in cancers IEEE Eng. Med. Biol. 2004, 23, 57-64
23. Gillies, R. J.; Raghunand, N.; Karczmar, G. S.; Bhujwalla, Z. M. MRI of the tumor microenvironment J. Magn. Reson. Imaging 2002, 16, 430-450 (Pubitemid 35167878)
24. Gerweck, L. E.; Kozin, S. V.; Stocks, S. J. The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells Br. J. Cancer 1999, 79, 838-842 (Pubitemid 29082114)
25. Raghunand, N.; Gillies, R. J. pH and drug resistance in tumors Drug Resist. Update 2000, 3, 39-47 (Pubitemid 30246567)
26. Mikkelsen, R. B.; Asher, C.; Hicks, T. Extracellular pH, transmembrane distribution and cytotoxicity of chlorambucil Biochem. Pharmacol. 1985, 34, 2531-2534 (Pubitemid 15063090)
27. Breiner, B.; Kaya, K.; Roy, S.; Yang, W. Y.; Alabugin, I. V. Hybrids of amino acids and acetylenic DNA-photocleavers: optimizing efficiency and selectivity for cancer phototherapy Org. Biomol. Chem. 2012, 10, 3974-3987
28. Yang, W. Y.; Roy, S.; Phrathep, B.; Rengert, Z.; Kenworthy, R.; Zorio, D. A.; Alabugin, I. V. Engineering pH-gated transitions for selective and efficient double-strand DNA photocleavage in hypoxic tumors J. Med. Chem. 2011, 54, 8501-8516
29. Lu, G. L.; Stevenson, R. J.; Chang, J. Y.; Brothers, P. J.; Ware, D. C.; Wilson, W. R.; Denny, W. A.; Tercel, M. N -Alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3- dihydro-1 H -pyrrolo[3, 2- f ]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugs Bioorgan. Med. Chem. 2011, 19, 4861-4867
30. Green, R. W.; Tong, H. K. Constitution of the pyridine monocarboxylic acids in their isoelectric forms J. Am. Chem. Soc. 1956, 78, 4896-4900
31. Schwarzenbach, G.; Schwarzenbach, K. Hydroxamate complexes. I. The stabilities of the iron(III) complexes of simple hydroxamic acids and desferriferrioxamin B Helv. Chim. Acta 1963, 46, 1390-1400
32. Mascharak, P. K. Structural and functional models of nitrile hydratase Coord. Chem. Rev. 2002, 225, 201-214
33. Wojtkowiak, J. W.; Verduzco, D.; Schramm, K. J.; Gillies, R. J. Drug resistance and cellular adaptation to tumor acidic pH microenvironment Mol. Pharmaceutics 2011, 8, 2032-2038
34. Bonny, C.; Coquoz, D.; Chen, J. Conjugates with enhanced cell uptake activity. EP patent 2004-269341656951, 2006.
35. Aguilera, T. A.; Olson, E. S.; Timmers, M. M.; Jiang, T.; Tsien, R. Y. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides Integr. Biol. 2009, 1, 371-381
36. Bryce, N. S.; Zhang, J. Z.; Whan, R. M.; Yamamoto, N.; Hambley, T. W. Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: the effect of charge on drug distribution in solid tumour models Chem. Commun. 2009, 19, 2673-2675
37. Zhang, J. Z.; Bryce, N. S.; Siegele, R.; Carter, E. A.; Paterson, D.; de Jonge, M. D.; Howard, D. L.; Ryan, C. G.; Hambley, T. W. The use of spectroscopic imaging and mapping techniques in the characterisation and study of DLD-1 cell spheroid tumour models Integr. Biol. 2012, 4, 1072-1080
38. Robey, R. W.; Chakraborty, A. R.; Basseville, A.; Luchenko, V.; Bahr, J.; Zhan, Z.; Bates, S. E. Histone deacetylase inhibitors: emerging mechanisms of resistance Mol. Pharmaceutics 2011, 8, 2021-2031
39. Anderegg, G.; Wenk, F. Pyridine derivatives as complexing agents. VIII. Preparation of a new quadridentate and a new hexadentate ligand Helv. Chim. Acta 1967, 50, 2330-2332
40. Chong, H.-S.; Torti, S. V.; Ma, R.; Torti, F. M.; Brechbiel, M. W. Synthesis and potent antitumor activities of novel 1,3,5- cis, cis -triaminocyclohexane N -pyridyl derivatives J. Med. Chem. 2004, 47, 5230-5234 (Pubitemid 39314920)
41. Yamaguchi, M.; Kumano, T.; Masui, D.; Yamagishi, T. Photoassisted oxygenation of alkane catalyzed by ruthenium complexes using 2,6-dichloropyridine N -oxide under visible light irradiation Chem. Commun. 2004, 10, 798-799 (Pubitemid 38530241)
42. Tyeklar, Z.; Jacobson, R. R.; Wei, N.; Murthy, N. N.; Zubieta, J.; Karlin, K. D. Reversible reaction of dioxygen (and carbon monoxide) with a copper(I) complex. X-ray structures of relevant mononuclear Cu(I) precursor adducts and the trans -(μ-1,2-peroxo)dicopper(II) product J. Am. Chem. Soc. 1993, 115, 2677-2689
43. Yamaguchi, M.; Kousaka, H.; Izawa, S.; Ichii, Y.; Kumano, T.; Masui, D.; Yamagishi, T. Syntheses, characterization, and catalytic ability in alkane oxygenation of chloro(dimethyl sulfoxide)ruthenium(II) complexes with tris(2-pyridylmethyl)amine and its derivatives Inorg. Chem. 2006, 45, 8342-8354
44. a′) for Broensted acids in aprotic solvents Anal. Chem. 1984, 56, 1890-1898 (Pubitemid 14624223)
45. Meites, L., Handbook of Analytical Chemistry; McGraw Hill: New York, 1963; p 1788.
46. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res. 1987, 47, 936-942 (Pubitemid 17027905)